Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 13, 2018 - Issue
Submit an article Journal homepage
69
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Health status in patients with COPD treated with roflumilast: two large noninterventional real-life studies: DINO and DACOTA

Peter Kardos1 Group Practice and Centre for Allergy, Respiratory, and Sleep Medicine, at Maingau Red Cross Hospital, Frankfurt am Main, GermanyCorrespondence[email protected]
,
Ingo Mokros2 AstraZeneca GmbH, Unternehmensbereich Medizin, Wedel, Germany
,
Rüdiger Sauer3 Group Practice with Respiratory, Allergy and Sleep Unite, Lung Center, Ulm, Germany;4 Health Center Clinic Blaubeuren, Blaubeuren, Germany
&
Claus F Vogelmeier5 Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University Marburg, Marburg, Germany;6 German Center for Lung Research (DZL), Giessen, Germany
Pages 1455-1468 | Published online: 03 May 2018

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Takudzwa Mkorombindo & Mark T Dransfield. (2019) Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1779-1787.
Read now
Aiyuan Zhou, Zijing Zhou, Yating Peng, Yiyang Zhao, Jiaxi Duan & Ping Chen. (2018) The role of CAT in evaluating the response to treatment of patients with AECOPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2849-2858.
Read now

Articles from other publishers (8)

Yazdan Hasani Nourian, Jafar Salimian, Ali Ahmadi, Zahra Salehi, Mehrdad Karimi, Alireza Emamvirdizadeh, Sadegh Azimzadeh Jamalkandi & Mostafa Ghanei. (2023) cAMP-PDE signaling in COPD: Review of cellular, molecular and clinical features. Biochemistry and Biophysics Reports 34, pages 101438.
Crossref
Maria Montes de Oca & Maria Eugenia Laucho-Contreras. (2023) Smoking cessation and vaccination. European Respiratory Review 32:167, pages 220187.
Crossref
Dave Singh, Simon Lea & Alexander G. Mathioudakis. (2021) Inhaled Phosphodiesterase Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease. Drugs 81:16, pages 1821-1830.
Crossref
Mirco Govoni, Michele Bassi, Stefano Vezzoli, Germano Lucci, Aida Emirova, Marie Anna Nandeuil, Stefano Petruzzelli, Gera L. Jellema, Ebenezer K. Afolabi, Brendan Colgan, Brian Leaker, Oliver Kornmann, Kai Michael Beeh, Henrik Watz & Dave Singh. (2020) Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis. Respiratory Research 21:1.
Crossref
Jørgen Vestbo, Christer Janson, Javier Nuevo & David Price. (2020) Observational studies assessing the pharmacological treatment of obstructive lung disease: strengths, challenges and considerations for study design. ERJ Open Research 6:4, pages 00044-2020.
Crossref
Imane Achir Alispahic, Rikke Sørensen, Josefin Eklöf, Pradeesh Sivapalan, Anders Løkke, Niels Seersholm, Jakob Hedemark Vestergaard & Jens-Ulrik Stæhr Jensen. (2020) Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations. Journal of Clinical Medicine 9:5, pages 1442.
Crossref
Hana Müllerová, Mark T. Dransfield, Byron Thomashow, Paul W. Jones, Stephen Rennard, Niklas Karlsson, Malin Fageras, Norbert Metzdorf, Stefano Petruzzelli, Jean Rommes, Frank C. Sciurba, Maggie Tabberer, Debora Merrill & Ruth Tal-Singer. (2020) Clinical Development and Research Applications of the Chronic Obstructive Pulmonary Disease Assessment Test. American Journal of Respiratory and Critical Care Medicine 201:9, pages 1058-1067.
Crossref
Dave Singh, Kai Michael Beeh, Brendan Colgan, Oliver Kornmann, Brian Leaker, Henrik Watz, Germano Lucci, Silvia Geraci, Aida Emirova, Mirco Govoni & Marie Anna Nandeuil. (2019) Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD. Respiratory Research 20:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.